Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shenglan Li

Showing results (121-130 of 128) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 128 results.
BMC Medicine|July 3, 2023
Phase 1 dose-escalation study to evaluate the safety, tolerability, pharmacokinetics, and anti-tumor activity of FCN-159 in adults with neurofibromatosis type 1-related unresectable plexiform neurofibromasXiaojie Hu, Wenbin Li, Kang Zeng, et al.
Cell Research|June 10, 2021
RNA m<sup>6</sup>A modification orchestrates a LINE-1-host interaction that facilitates retrotransposition and contributes to long gene vulnerabilityFeng Xiong, Ruoyu Wang, Joo-Hyung Lee, et al.
Kidney International|May 10, 2023
Peroxiredoxin 1 aggravates acute kidney injury by promoting inflammation through Mincle/Syk/NF-κB signalingShenglan Li, Yan Zhang, Rong Lu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 8, 2026
Caveolin-1 Stabilizes SERCA2 to Counteract Acute Kidney Injury via Suppression of Ca<sup>2+</sup>-Dependent Endoplasmic Reticulum Stress in Distal TubulesYan Zhang, Xin He, Hao Huang, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
The Utility of Ultra-Deep RNA sequencing in Mendelian Disorder DiagnosticsSen Zhao, Jefferson C Sinson, Shenglan Li, et al.
American Journal of Human Genetics|October 11, 2025
The utility of ultra-deep RNA sequencing in Mendelian disorder diagnosticsSen Zhao, Jefferson C Sinson, Shenglan Li, et al.
Acta Pharmaceutica Sinica. B|December 4, 2023
Preclinical and early clinical studies of a novel compound SYHA1813 that efficiently crosses the blood-brain barrier and exhibits potent activity against glioblastomaYingqiang Liu, Zhengsheng Zhan, Zhuang Kang, et al.
American Journal of Human Genetics|April 9, 2024
The clinical utility and diagnostic implementation of human subject cell transdifferentiation followed by RNA sequencingShenglan Li, Sen Zhao, Jefferson C Sinson, et al.
Pageof 13

Showing results (121-130 of 128) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 128 results.
BMC Medicine|July 3, 2023
Phase 1 dose-escalation study to evaluate the safety, tolerability, pharmacokinetics, and anti-tumor activity of FCN-159 in adults with neurofibromatosis type 1-related unresectable plexiform neurofibromasXiaojie Hu, Wenbin Li, Kang Zeng, et al.
Cell Research|June 10, 2021
RNA m<sup>6</sup>A modification orchestrates a LINE-1-host interaction that facilitates retrotransposition and contributes to long gene vulnerabilityFeng Xiong, Ruoyu Wang, Joo-Hyung Lee, et al.
Kidney International|May 10, 2023
Peroxiredoxin 1 aggravates acute kidney injury by promoting inflammation through Mincle/Syk/NF-κB signalingShenglan Li, Yan Zhang, Rong Lu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 8, 2026
Caveolin-1 Stabilizes SERCA2 to Counteract Acute Kidney Injury via Suppression of Ca<sup>2+</sup>-Dependent Endoplasmic Reticulum Stress in Distal TubulesYan Zhang, Xin He, Hao Huang, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
The Utility of Ultra-Deep RNA sequencing in Mendelian Disorder DiagnosticsSen Zhao, Jefferson C Sinson, Shenglan Li, et al.
American Journal of Human Genetics|October 11, 2025
The utility of ultra-deep RNA sequencing in Mendelian disorder diagnosticsSen Zhao, Jefferson C Sinson, Shenglan Li, et al.
Acta Pharmaceutica Sinica. B|December 4, 2023
Preclinical and early clinical studies of a novel compound SYHA1813 that efficiently crosses the blood-brain barrier and exhibits potent activity against glioblastomaYingqiang Liu, Zhengsheng Zhan, Zhuang Kang, et al.
American Journal of Human Genetics|April 9, 2024
The clinical utility and diagnostic implementation of human subject cell transdifferentiation followed by RNA sequencingShenglan Li, Sen Zhao, Jefferson C Sinson, et al.
Pageof 13